PP_1170x120_10-25-21

wearable watch and patch for non-invasive cuffless monitoring of blood pressure

FDA clears Biobeat’s wearable watch and patch for non-invasive cuffless monitoring of blood pressure

FDA clears Biobeat’s wearable watch and patch for non-invasive cuffless monitoring of blood pressure

TEL AVIV — Biobeat, a bio-medical technology company developing advanced sensing and remote monitoring solutions for patients, announced Monday that the U.S. Food and Drug Administration (FDA) has granted a 510K clearance for its patch and watch for measurement of blood pressure, oxygenation and heart rate in hospitals, clinics, long-term care and at home. Biobeat’s products

Adheris Health